Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients ages 10-65 years, inclusive~  * Patient suffers from either~    * diarrhea for more than 6 weeks and less than 3 years and/or~   * abdominal pain for more than 6 weeks and less than 3 years and/or~   * extra-luminal manifestations of IBD including: erythema nodosum, pyoderma gangrenosum, arthritis, peri-anal disease, uveitis, aphthous stomatitis~ * Patient suffers from at least one of the symptoms / lab abnormalities listed below:~    * Positive inflammatory marker (ESR, CRP, thrombocytosis, leukocytosis, fecal lactoferrin, fecal alpha-1 antitrypsin) within 3 months prior to enrollment~   * Unexplained anemia (less than normal limits) within 3 months prior to enrollment~   * Hypoalbuminemia (\<3.5 g/dl) within 3 months of enrollment~   * Positive ASCA within 3 months of enrollment~   * Abnormal white blood cell scan with in 3 months of enrollment~   * Stool negative for O\&P (C\&S) within 3 months of enrollment~   * Recurrent Fevers~   * Unexplained weight loss, failure to thrive in children~   * Gastro-intestinal bleeding including melena and/or hematochezia and/or FOBT positive.~   * Chronic perianal disease (fistula, fissure, peri-rectal abscess)~   * Abnormal small bowel SBFT and/or enteroclysis and/or abdominal CT not conclusively diagnostic for IBD~ * Patient is indicated for Ileo-Colonoscopy~ * Patient or legal guardian agrees to sign consent form~Exclusion criteria:~* Indeterminate Colitis where the purpose is only to make a definitive diagnosis and where the inclusion criteria are not otherwise met~* Known intestinal obstruction or current obstructive symptoms, such as severe abdominal pain with accompanying nausea or vomiting.~* Definite long stricture seen on radiological exam.~* Suspected GI stricture, followed by agile™ study that could not prove patency of the GI tract.~* Known history of small bowel Crohn's Disease~* Current treatment for active IBD~* Positive Anti-tTG or anti-endomysial antibody~* Any of the following work-up within 1 year of study entry: Capsule Endoscopy, Colonoscopy and Upper GI/SBFT.~* Non-steroidal anti-inflammatory drugs including Aspirin, (twice weekly or more) during the 4 weeks preceding enrollment~* Patient is pregnant

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).